NCT01120717 - A Study to Assess the Long-term Safety of QVA149 | Biotech Hunter

Enrollment

339

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG

QVA149

capsules for inhalation, delivered by an SDDPI

DRUG

Placebo

capsules for inhalation, delivered by an SDDPI

Trial Locations (53)

1002

Novartis Investigative Site, Riga

2030

Novartis Investigative Site, Érd

2100

Novartis Investigative Site, Gödöllő

2170

Novartis Investigative Site, Aszód

6500

Novartis Investigative Site, Baja

6900

Novartis Investigative Site, Makó

10457

Novartis Investigative Site, Bucharest

33604

Novartis Investigative Site, Pessac

34059

Novartis Investigative Site, Montpellier

44000

Novartis Investigative Site, Nantes

44320

Novartis Investigative Site, Kaunas

62660

Novartis Investigative Site, Beuvry

77150

Novartis Investigative Site, Ferolles-Attily

92288

Novartis Investigative Site, Klaipėda

110029

Novartis Investigative Site, New Delhi

110063

Novartis Investigative Site, Dehli

400007

Novartis Investigative Site, Mumbai

452001

Novartis Investigative Site, Indore

500118

Novartis Investigative Site, Brasov

560027

Novartis Investigative Site, Banglaore

570004

Novartis Investigative Site, Mysore

641044

Novartis Investigative Site, Coimbatore

700115

Novartis Investigative Site, Iași

M3H 5S4

Novartis Investigative Site, Toronto

J7J 2K8

Novartis Investigative Site, Mirabel

G1G 3Z4

Novartis Investigative Site, Québec

G1P 1J6

Novartis Investigative Site, Québec

600 087

Novartis Investigative Site, Chennai - Tamil Nadu

Unknown

Novartis Investigative Site, Mangalore

Novartis Investigative Site, Pretoria

LV-1038

Novartis Investigative Site, Riga

LV-5401

Novartis Investigative Site, Daugavpils

LV-5201

Novartis Investigative Site, Jēkabpils

LT-62114

Novartis Investigative Site, Alytus

LT-92231

Novartis Investigative Site, Klaipėda

06001

Novartis Investigative Site, Vilnius

LT-08661

Novartis Investigative Site, Vilnius

011422

Novartis Investigative Site, Bucharest

030303

Novartis Investigative Site, Bucharest

0184

Novartis Investigative Site, Pretoria

602-739

Novartis Investigative Site, Busan

410-773

Novartis Investigative Site, Koyang-si

140-743

Novartis Investigative Site, Seoul

158-710

Novartis Investigative Site, Seoul

CB7 5JD

Novartis Investigative Site, Cambridge

WD25 0EA

Novartis Investigative Site, Watford

BA1 2SR

Novartis Investigative Site, Bath

BA2 3HT

Novartis Investigative Site, Bath

S40 4TF

Novartis Investigative Site, Chesterfield

G69 7AD

Novartis Investigative Site, Glasgow

KA12 0AY

Novartis Investigative Site, Irvine

FY3 7EN

Novartis Investigative Site, Lancashire

NN8 4RW

Novartis Investigative Site, Wellingborough